MICHAEL J HUANG
Allopathic & Osteopathic Physicians|Internal Medicine BOSTON, MA NPI 1295962397
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine MA Takeda Pharmaceuticals U.S.A., Inc. All categories
General Payments — all program years on this page
$3,512.11
- Category: General Payments
- Program years: PY2018–2024
- Record count: 132
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,279.76 across 46 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,255.57 | 44 |
| Education | $24.19 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $171.81 | 6 |
| Gilead Sciences, Inc. | $162.64 | 3 |
| ABBVIE INC. | $161.68 | 9 |
| Janssen Biotech, Inc. | $160.66 | 3 |
| PFIZER INC. | $88.46 | 3 |
| Ardelyx, Inc. | $75.23 | 4 |
| Lilly USA, LLC | $55.21 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $55.10 | 2 |
| Organon LLC | $48.41 | 2 |
| Alnylam Pharmaceuticals Inc. | $42.48 | 2 |
| Regeneron Healthcare Solutions, Inc. | $39.32 | 2 |
| Madrigal Pharmaceuticals | $35.68 | 1 |
| GENZYME CORPORATION | $34.43 | 1 |
| IRONWOOD PHARMACEUTICALS, INC | $29.79 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.91 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $27.71 | 1 |
| Ipsen Biopharmaceuticals, Inc | $25.27 | 1 |
| QOL Medical, LLC | $20.52 | 1 |
| Celltrion USA Inc. | $17.45 | 1 |
By program year
Records — PY2024 (46)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.